Valeant Pharma (VRX) 1.3M Shares Pledged on Behalf of Pearson Sold by Goldman Sachs

Go back to Valeant Pharma (VRX) 1.3M Shares Pledged on Behalf of Pearson Sold by Goldman Sachs

Valeant Pharma (VRX) Sees 'Dead Cat Bounce' after CEO Hit with Margin Call

November 6, 2015 12:19 PM EST

Valeant Pharma (NYSE: VRX) is pushing to the highs of the session, following earlier news that about 1.3 million shares CEO Mike Pearson had pledged on a loan were sold yesterday due to margins calls.

The news suggests that some of the... More